These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 2961582

  • 1. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L, Mellin C, Hacksell U, Andén NE.
    Eur J Pharmacol; 1987 Nov 03; 143(1):55-63. PubMed ID: 2961582
    [Abstract] [Full Text] [Related]

  • 2. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T.
    Eur J Pharmacol; 1996 May 15; 303(3):151-62. PubMed ID: 8813561
    [Abstract] [Full Text] [Related]

  • 3. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Tricklebank MD, Forler C, Fozard JR.
    Eur J Pharmacol; 1984 Nov 13; 106(2):271-82. PubMed ID: 6241568
    [Abstract] [Full Text] [Related]

  • 4. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun 13; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 5. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H.
    J Med Chem; 1987 Nov 13; 30(11):2105-9. PubMed ID: 2959776
    [Abstract] [Full Text] [Related]

  • 6. Partial postsynaptic 5-HT1A agonist properties of the novel stereoselective 8-OH-DPAT analogue (+)cis-8-hydroxy-1-methyl-2-(di-n-propylamino)tetralin, (+)ALK-3.
    Hjorth S, Sharp T, Hacksell U.
    Eur J Pharmacol; 1989 Nov 07; 170(3):269-74. PubMed ID: 2533557
    [Abstract] [Full Text] [Related]

  • 7. Different effects on the responses of functional pre- and postsynaptic 5-HT1A receptors by repeated treatment of rats with the 5-HT1A receptor agonist 8-OH-DPAT.
    Larsson LG, Rényi L, Ross SB, Svensson B, Angeby-Möller K.
    Neuropharmacology; 1990 Feb 07; 29(2):85-91. PubMed ID: 1691832
    [Abstract] [Full Text] [Related]

  • 8. Evidence for selective inhibition of limbic forebrain dopamine synthesis by 8-OH-DPAT in the rat.
    Ahlenius S, Hillegaart V, Wijkström A.
    Naunyn Schmiedebergs Arch Pharmacol; 1989 May 07; 339(5):551-6. PubMed ID: 2570361
    [Abstract] [Full Text] [Related]

  • 9. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
    Yamada J, Sugimoto Y, Horisaka K.
    Eur J Pharmacol; 1988 Sep 23; 154(3):299-304. PubMed ID: 2976671
    [Abstract] [Full Text] [Related]

  • 10. Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-8-hydroxy-2-(dipropylamino)tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)tetralin-induced effects.
    Björk L, Cornfield LJ, Nelson DL, Hillver SE, Andén NE, Lewander T, Hacksell U.
    J Pharmacol Exp Ther; 1991 Jul 01; 258(1):58-65. PubMed ID: 1830099
    [Abstract] [Full Text] [Related]

  • 11. 8-Hydroxy-2-(di-n-propylamino) tetralin is devoid of activity at the 5-hydroxytryptamine autoreceptor in rat brain. Implications for the proposed link between the autoreceptor and the [3H] 5-HT recognition site.
    Middlemiss DN.
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug 01; 327(1):18-22. PubMed ID: 6238235
    [Abstract] [Full Text] [Related]

  • 12. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
    Björk L, Höök BB, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1989 Apr 01; 32(4):779-83. PubMed ID: 2522991
    [Abstract] [Full Text] [Related]

  • 13. Characteristics of feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
    Dourish CT, Hutson PH, Curzon G.
    Brain Res Bull; 1985 Oct 01; 15(4):377-84. PubMed ID: 2933126
    [Abstract] [Full Text] [Related]

  • 14. Median raphe, but not dorsal raphe, application of the 5-HT1A agonist 8-OH-DPAT stimulates rat motor activity.
    Hillegaart V, Hjorth S.
    Eur J Pharmacol; 1989 Jan 31; 160(2):303-7. PubMed ID: 2527161
    [Abstract] [Full Text] [Related]

  • 15. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM, Green AR.
    Br J Pharmacol; 1985 Mar 31; 84(3):743-53. PubMed ID: 2580582
    [Abstract] [Full Text] [Related]

  • 16. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
    Engel JA, Hjorth S, Svensson K, Carlsson A, Liljequist S.
    Eur J Pharmacol; 1984 Oct 15; 105(3-4):365-8. PubMed ID: 6239785
    [Abstract] [Full Text] [Related]

  • 17. Effect of 8-hydroxy-2-(di-n-propylamino) tetralin on rat prolactin secretion.
    Simonovic M, Gudelsky GA, Meltzer HY.
    J Neural Transm; 1984 Oct 15; 59(2):143-9. PubMed ID: 6233394
    [Abstract] [Full Text] [Related]

  • 18. Suppression of lordosis behavior by the putative 5-HT receptor agonist 8-OH-DPAT in the rat.
    Ahlenius S, Fernandez-Guasti A, Hjorth S, Larsson K.
    Eur J Pharmacol; 1986 May 27; 124(3):361-3. PubMed ID: 2942412
    [Abstract] [Full Text] [Related]

  • 19. Effect of 8-hydroxy-2-(di-n-propylamino)-tetralin on the tryptophan-induced increase in 5-hydroxytryptophan accumulation in rat brain.
    Fernstrom MH, Massoudi MS, Fernstrom JD.
    Life Sci; 1990 May 27; 47(4):283-9. PubMed ID: 2143798
    [Abstract] [Full Text] [Related]

  • 20. Increased dopamine turnover in the ventral striatum by 8-OH-DPAT administration in the rat.
    Ahlenius S, Hillegaart V, Wijkström A.
    J Pharm Pharmacol; 1990 Apr 27; 42(4):285-8. PubMed ID: 1974300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.